Twitter(TWTR.US)同意10月17日開庭 憂馬斯克試圖拖延審訊
Twitter(TWTR.US)不反對Tesla(TSLA.US)行政總裁馬斯克要求法院在10月17日開始審理他放棄收購Twitter的案件,而Twitter亦在法庭文件中表示,希望法院承諾在五天內完成審訊。
馬斯克表示,需要時間來完成Twitter對假賬戶作虛假陳述的徹底調查,因這是違反雙方的交易條款。他最初要求在明年2月進行審訊,但法官裁定訴訟將在3個月內開始後,因此馬斯克提出在10月17日進行。
Twitter一直稱馬斯克對虛假賬戶的指控純粹在分散注意力,要求儘快開庭審理,認爲案件繼續被拖延將會影響公司業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.